Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
SF enters its October 21 Q3 earnings release down 12% over the past month, with a broad analyst target-trimming cycle framing the debate heading into the print.
The clearest pre-earnings signal is the direction of Street estimates. Four analysts cut their price targets in the two weeks before the report, covering TD Cowen, UBS, JP Morgan and BMO Capital. None changed their ratings: the cuts reflect a recalibration of the upside case rather than a shift in conviction. TD Cowen's Bill Katz trimmed to $78 on October 12, while JP Morgan and BMO cut to $82 and $75 respectively on October 6. UBS, which carries a Buy, pulled its target from $90 to $84 on October 7. The mean target now stands at $84.50, roughly 25% above the current price of $67.56, a gap that has widened mechanically as the stock has fallen rather than through a wave of new positive catalysts. The question heading into the print is whether Q3 results can give bulls the foothold to close that gap.
Short interest and borrowing conditions offer no meaningful overlay. At 4.2% of the free float, with borrow cost at just 0.32% and share availability extraordinarily deep, there is no pressure from the short side that the market is treating as a real thesis. Short interest fell 5.8% over the past week, adding to the picture of a market where the strain is in price weakness, not active short conviction. Options positioning is similarly subdued: the put/call ratio of 0.17 is fractionally below its 20-day average, meaning the options market is not adding a defensive tilt above what has been normal.
The FDIC call report data for Stifel's insured bank charters, published by the Federal Deposit Insurance Corporation, flagged record Q2 total assets of $35.5 billion and record Q2 deposits of $32.3 billion for that period, both the largest since the data series began in 2024. The dataset has not yet been tested against the company's reported figures as a leading indicator, so it provides context on the balance sheet, not a signal about where Q3 numbers land.
Peers have broadly sold off on the week too, with BX down 6.7%, CG and KKR each down around 5%, and STT down 5.3%. SF's 4% weekly decline is softer than the peer median, suggesting this is a sector-wide repricing rather than a stock-specific event. After the last Q2 print, SF gained 2.5% on the day and 5.6% over the following week. Tuesday's report will test whether the combination of record balance-sheet readings and a heavily discounted share price is enough to reverse a three-month drawdown that has outpaced most of its closest peers.
See the live data behind this article on ORTEX.
Open SF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
